R&G PharmaStudies Co., Ltd. (SHE:301333)
China
· Delayed Price · Currency is CNY 63.47
-2.36 (-3.58%)
At close: Apr 29, 2026
R&G PharmaStudies Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Revenue | 896.26 | 851.01 | 744 | 721.37 | 637.52 | 608.43 | Upgrade
|
| Revenue Growth (YoY) | 21.20% | 14.38% | 3.14% | 13.15% | 4.78% | 25.59% | Upgrade
|
| Cost of Revenue | 597.9 | 555.36 | 468.08 | 434.34 | 402.62 | 375.25 | Upgrade
|
| Gross Profit | 298.35 | 295.64 | 275.92 | 287.04 | 234.9 | 233.17 | Upgrade
|
| Selling, General & Admin | 101.77 | 102 | 91.29 | 94.45 | 75.34 | 71.85 | Upgrade
|
| Research & Development | 63.01 | 61.97 | 56.83 | 52.86 | 49.99 | 41.19 | Upgrade
|
| Other Operating Expenses | 3.71 | 3.98 | 3.39 | 3.76 | 3.01 | 3.43 | Upgrade
|
| Operating Expenses | 173.68 | 173.13 | 154.88 | 155.93 | 131.92 | 124.02 | Upgrade
|
| Operating Income | 124.68 | 122.51 | 121.05 | 131.11 | 102.98 | 109.15 | Upgrade
|
| Interest Expense | -2.86 | -2.86 | -3.44 | -0.6 | -0.67 | -0.58 | Upgrade
|
| Interest & Investment Income | 19.67 | 21.25 | 23.17 | 34.6 | 15.04 | 5.46 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.47 | -3.47 | 1.72 | 1.38 | 5.73 | -1.34 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.29 | -0.38 | -1.79 | -0.35 | -0.58 | -0.41 | Upgrade
|
| EBT Excluding Unusual Items | 135.72 | 137.05 | 140.7 | 166.14 | 122.5 | 112.28 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.76 | 10.95 | 11.28 | 3.98 | 0.91 | -2.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.07 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Asset Writedown | -0.9 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 7.16 | 7.16 | 5.87 | 12.37 | 5.5 | 3.44 | Upgrade
|
| Pretax Income | 151.74 | 155.15 | 157.79 | 182.47 | 128.89 | 113.6 | Upgrade
|
| Income Tax Expense | 16.97 | 16.85 | 16 | 19.61 | 14.75 | 13.24 | Upgrade
|
| Earnings From Continuing Operations | 134.77 | 138.29 | 141.79 | 162.86 | 114.13 | 100.35 | Upgrade
|
| Minority Interest in Earnings | -1.12 | -1.39 | -1.57 | -0.33 | -0.69 | -1.12 | Upgrade
|
| Net Income | 133.65 | 136.9 | 140.22 | 162.53 | 113.45 | 99.24 | Upgrade
|
| Net Income to Common | 133.65 | 136.9 | 140.22 | 162.53 | 113.45 | 99.24 | Upgrade
|
| Net Income Growth | -6.70% | -2.37% | -13.73% | 43.27% | 14.32% | 18.37% | Upgrade
|
| Shares Outstanding (Basic) | 95 | 96 | 95 | 96 | 82 | 72 | Upgrade
|
| Shares Outstanding (Diluted) | 95 | 96 | 95 | 96 | 82 | 72 | Upgrade
|
| Shares Change (YoY) | -0.16% | 0.36% | -0.64% | 16.78% | 14.43% | -0.38% | Upgrade
|
| EPS (Basic) | 1.40 | 1.43 | 1.47 | 1.69 | 1.38 | 1.38 | Upgrade
|
| EPS (Diluted) | 1.40 | 1.43 | 1.47 | 1.69 | 1.38 | 1.38 | Upgrade
|
| EPS Growth | -6.55% | -2.72% | -13.17% | 22.68% | -0.09% | 18.82% | Upgrade
|
| Free Cash Flow | 88.52 | 94.93 | 134.78 | 172.68 | 109.64 | 76.29 | Upgrade
|
| Free Cash Flow Per Share | 0.93 | 0.99 | 1.41 | 1.80 | 1.33 | 1.06 | Upgrade
|
| Dividend Per Share | 0.160 | 0.160 | 0.160 | 0.200 | 0.156 | - | Upgrade
|
| Dividend Growth | - | - | -20.00% | 27.96% | - | - | Upgrade
|
| Gross Margin | 33.29% | 34.74% | 37.09% | 39.79% | 36.85% | 38.32% | Upgrade
|
| Operating Margin | 13.91% | 14.40% | 16.27% | 18.18% | 16.15% | 17.94% | Upgrade
|
| Profit Margin | 14.91% | 16.09% | 18.85% | 22.53% | 17.79% | 16.31% | Upgrade
|
| Free Cash Flow Margin | 9.88% | 11.15% | 18.12% | 23.94% | 17.20% | 12.54% | Upgrade
|
| EBITDA | 127.36 | 129.32 | 144.37 | 153.73 | 110.43 | 135.31 | Upgrade
|
| EBITDA Margin | 14.21% | 15.20% | 19.40% | 21.31% | 17.32% | 22.24% | Upgrade
|
| D&A For EBITDA | 2.68 | 6.81 | 23.32 | 22.62 | 7.44 | 26.16 | Upgrade
|
| EBIT | 124.68 | 122.51 | 121.05 | 131.11 | 102.98 | 109.15 | Upgrade
|
| EBIT Margin | 13.91% | 14.40% | 16.27% | 18.18% | 16.15% | 17.94% | Upgrade
|
| Effective Tax Rate | 11.18% | 10.86% | 10.14% | 10.75% | 11.45% | 11.66% | Upgrade
|
| Revenue as Reported | 851.01 | 851.01 | 744 | 721.37 | 637.52 | 608.43 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 1.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.